Live Q&A: CDC May Limit J&J Vaccine Over Complications; Hospitals Get Incentives on COVID-19 Treatments

Published: Dec. 17, 2021, 4:28 a.m.

he Centers for Disease Control and Prevention (CDC) is considering whether it should stop the use of the Johnson & Johnson COVID-19 vaccine over cases of it causing blood clots, which have been seen more in young and middle-aged women. The Washington Post reports that \u201cthe Advisory Committee on Immunization Practices will be presented with new data that appears to show the rate of the clots in people who received the Johnson & Johnson shot has increased since April, although the problem is still rare.\u201d

In other news, a report from the Association of American Physicians and Surgeons details how hospitals get incentive payments for patients of COVID-19, and details how these incentives could limit patient care and possibly harm patients.

In this live Q&A with Crossroads host Joshua Philipp, we\u2019ll discuss these stories and others, and answer questions from the audience.

\u2b55\ufe0f Stay up-to-date with Josh with the Crossroads NEWSLETTER\U0001f449 https://ept.ms/CrossroadsNewsletter
\u2b55\ufe0f Support our fight for the truth\U0001f449 https://donorbox.org/crossroads